Nasal Spray Recall Issued Due to Superpotency, Which May Result in Seizure, Coma and Death

A recall has been issue for certain types of nasal sprays, due to a risk they may contain dangerous levels of the active ingredient desmopressin, which may cause consumers to experience serious adverse health consequences, including seizures, coma or death.

The FDA announced the Ferring Pharmaceuticals Nasal Spray recall on August 5, following routine testing that discovered certain products had “superpotency”, or high amounts of desmopressin, which could cause harm to consumers.

Officials warn that symptoms of a desmopressin overdose may include confusion, drowsiness, continuing headache, problems with passing urine and rapid weight gain due to fluid retention. In severe cases, patients with abnormally low levels of sodium in the blood could be subject to experiencing seizure, coma or even death.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

Desmopressin is a man-made form of hormone designed to regulate how the body uses water. To date, officials have become aware of at least one adverse event potentially associated with the recalled products.

The recall includes DDAVP® Nasal Spray 10 mcg/0.1 mL, 5 mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1 mL, 5 mL, and Stimate® Nasal Spray 1.5 mg/mL, 2.5 mL products sold at the consumer level.

DDAVP® Nasal Sprays and Desmopressin Acetate Nasal Spray are intended to be used as fluid control replacement therapy for patients suffering from central cranial diabetes insipidus and for the management of individuals suffering from urinary complications. Stimate® Nasal Sprays are used to treat patients with genetic disorders and Williebrand’s disease, which is a bleeding disorder caused by low levels of clotting protein in the blood.

The nasal sprays were manufactured by Ferring Pharmaceuticals US of Parsippany, New Jersey where they were distributed for sale throughout the United States.

Ferring US has begun notifying its distributors and wholesale customers instructing them to check for any remaining recalled products and to return them through directions provided in the notice.

Customers are being encouraged to contact their healthcare provider immediately and report all adverse health consequences or quality problems to the FDA’s MedWatch Adverse Event Reporting program.


  • SamFebruary 10, 2021 at 6:19 am

    I had blood work completed that revealed very low sodium. I was ordered to go to the hospital by my doctor and spent a couple of weeks confused and sick. On top of it all, I also lost my job.

  • RobinAugust 30, 2020 at 5:26 pm

    This upsets me, my daughter was prescribed Desmopressin 1.5 mg

  • MaddieAugust 25, 2020 at 4:11 pm

    My child was on Desmopressin 10mcg/ 0.1 ML nasal spray. He did have a seizure last year and was unable to walk for a week due to muscle damage. We thought he had just gotten sick, but nobody else in the house ever got ill during this time.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories